<?xml version="1.0" encoding="UTF-8"?>
<p id="Par56">A recent systematic review concluded that evaluating the potentially favorable benefit–risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of COVID-19 in the present context of outbreak; however, the respective national guidelines and clinician’s evaluation and decision are recommended [
 <xref ref-type="bibr" rid="CR47">47</xref>•].
</p>
